日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Refining Risk Assessment for Adjuvant CDK4/6 Inhibitors beyond Trial Inclusion Criteria: Integrating Recurrence Score and Endocrine Responsiveness according to ADAPT

完善辅助性 CDK4/6 抑制剂的风险评估,超越临床试验纳入标准:根据 ADAPT 整合复发评分和内分泌反应性

Braun, Michael; Gluz, Oleg; Kuemmel, Sherko; Nitz, Ulrike; Luedtke-Heckenkamp, Kerstin; Darsow, Maren; Forstbauer, Helmut; Polata, Silke; Grischke, Eva-Maria; Uleer, Christoph; Aktas, Bahriye; Schumacher, Claudia; Zu Eulenburg, Christine; Kates, Ronald; Burmeister, Sandy; Graeser, Monika; Wuerstlein, Rachel; Baehner, Rick; Christgen, Matthias; Kreipe, Hans Heinrich; Harbeck, Nadia

Immunomodulatory gene networks predict treatment response and survival to de-escalated, anthracycline-free neoadjuvant chemotherapy in triple-negative breast cancer in the WSG-ADAPT-TN trial

在WSG-ADAPT-TN试验中,免疫调节基因网络可预测三阴性乳腺癌患者对降阶梯、不含蒽环类药物的新辅助化疗的治疗反应和生存期。

Korbie, Darren; Stirzaker, Clare; Gluz, Oleg; Zu Eulenburg, Christine; Nitz, Ulrike; Christgen, Matthias; Kuemmel, Sherko; Grischke, Eva-Maria; Forstbauer, Helmut; Braun, Michael; Warm, Mathias; Hackmann, John; Uleer, Christoph; Aktas, Bahriye; Schumacher, Claudia; Wuerstlein, Rachel; Pelz, Enrico; Kreipe, Hans Heinrich; Clark, Susan J; Trau, Matt; Graeser, Monika; Harbeck, Nadia

600- vs 400-mg First-Line Ribociclib in Hormone Receptor-Positive/ERBB2-Negative Advanced Breast Cancer: The AMALEE Randomized Clinical Trial

600毫克与400毫克一线瑞博西尼治疗激素受体阳性/ERBB2阴性晚期乳腺癌:AMALEE随机临床试验

Cardoso, Fatima; Jacot, William; Kuemmel, Sherko; Gupta, Sudeep; Cruz, Felipe; Balaraman, Rama; Ferreira, Ana; Ahola, Tytti; Chapko, Yana; Zhukova, Lyudmila; Chiang, Wendy; Li, Zheng; Ji, Yan; Kaakiou, Nadia; Bolotova, Natalia; Sparano, Joseph A

A First-in-Class mAb (BI-1607) Targeting FcγRIIB: Preclinical Data and First-in-Human Studies in Patients with HER2-Positive Advanced Solid Tumors

首个靶向FcγRIIB的单克隆抗体(BI-1607):HER2阳性晚期实体瘤患者的临床前数据和首次人体研究

Cortés, Javier; Priego, Araceli; Garralda, Elena; Rojas, Katerin; Lord, Simon R; Goetze, Thorsten O; Kuemmel, Sherko; Crabb, Simon J; Parra-Guillen, Zinnia P; Borggren, Marie; Karlsson, Ingrid; Lindahl, Danijela; Mårtensson, Linda; Oldham, Robert; Ropenga, Anna; Teige, Ingrid; Wallin, Johan; Frendeus, Björn; McAllister, Andres

Genetic Alterations, Therapy Response, and Survival Among Patients With Triple-Negative Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial

三阴性乳腺癌患者的基因改变、治疗反应和生存率:一项随机临床试验的二次分析

Richters, Lisa; Gluz, Oleg; Weber-Lassalle, Nana; Christgen, Matthias; Haverkamp, Heinz; Kuemmel, Sherko; Kayali, Mohamad; Kates, Ronald E; Grischke, Eva-Maria; Altmüller, Janine; Forstbauer, Helmut; Thiele, Holger; Braun, Michael; Warm, Mathias; Ossowski, Anna; Wuerstlein, Rachel; Ernst, Corinna; Graeser, Monika; Linn, Sabine C; Nitz, Ulrike; Hauke, Jan; Kreipe, Hans Heinrich; Schmutzler, Rita K; Hahnen, Eric; Harbeck, Nadia

Endocrine response assessment in HR-positive HER2-negative early breast cancer: concordance of local versus central Ki67 measurements in the WSG ADAPTcycle trial (n = 5292)

HR阳性HER2阴性早期乳腺癌的内分泌反应评估:WSG ADAPTcycle试验中局部与中心Ki67测量的一致性(n = 5292)

Hamann, M; Christgen, M; Gluz, O; Nitz, U; Kuemmel, S; Braun, M; Thill, M; Wuerstlein, R; Wimberger, P; Hartkopf, A; Schem, C; Zaiss, M; Bjelic-Radisic, V; Just, M; Veselinovic, K; Vincent, M; Graeser, M; Krauss, K; Hoffmann, O; Lüdtke-Heckenkamp, K; Kates, R E; Zu Eulenburg, C; Jóźwiak, K; Burmeister, S; Hauptmann, M; Baehner, F; Schmid, P; Kreipe, H-H; Harbeck, N

Safety and efficacy of tiragolumab, atezolizumab and chemotherapy for early-stage or PD-L1-positive advanced triple-negative breast cancer: a phase Ib study

tiragolumab、atezolizumab 和化疗治疗早期或 PD-L1 阳性晚期三阴性乳腺癌的安全性和有效性:一项 Ib 期研究

Kuemmel, S; Jung, K H; Andrade, L; Assad-Suzuki, D; de la Cruz Merino, L; Freitas-Junior, R; Hegg, R; Huang, C-S; Martin, H; Schneeweiss, A; Dieterich, M; Nguyen Duc, A; Feng, Y; Meng, R; Swat, A; Seiller, A; Bermejo, B; Hamilton, E P

Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in gBRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer

OlympiA 研究的患者报告结局:一项针对 gBRCA1/2 突变和高危人表皮生长因子受体 2 阴性早期乳腺癌患者的奥拉帕尼辅助治疗 III 期随机、安慰剂对照试验

Ganz, Patricia A; Bandos, Hanna; Španić, Tanja; Friedman, Sue; Müller, Volkmar; Kuemmel, Sherko; Delaloge, Suzette; Brain, Etienne; Toi, Masakazu; Yamauchi, Hideko; de Dueñas, Eduardo-M; Armstrong, Anne; Im, Seock-Ah; Song, Chuan-Gui; Zheng, Hong; Sarosiek, Tomasz; Sharma, Priyanka; Geng, Cuizhi; Fu, Peifen; Rhiem, Kerstin; Frauchiger-Heuer, Heike; Wimberger, Pauline; t'Kint de Roodenbeke, Daphné; Liao, Ning; Goodwin, Annabel; Chakiba-Brugère, Camille; Friedlander, Michael; Lee, Keun Seok; Giacchetti, Sylvie; Takano, Toshimi; Henao-Carrasco, Fernando; Virani, Shamsuddin; Valdes-Albini, Frances; Domchek, Susan M; Bane, Charles; McCarron, Edward C; Mita, Monica; Rossi, Giovanna; Rastogi, Priya; Fielding, Anitra; Gelber, Richard D; Scheepers, Elsemieke D; Cameron, David; Garber, Judy; Geyer, Charles E; Tutt, Andrew N J

Omission of Axillary Dissection Following Nodal Downstaging With Neoadjuvant Chemotherapy

新辅助化疗后淋巴结降期,无需行腋窝淋巴结清扫术

Montagna, Giacomo; Mrdutt, Mary M; Sun, Susie X; Hlavin, Callie; Diego, Emilia J; Wong, Stephanie M; Barrio, Andrea V; van den Bruele, Astrid Botty; Cabioglu, Neslihan; Sevilimedu, Varadan; Rosenberger, Laura H; Hwang, E Shelley; Ingham, Abigail; Papassotiropoulos, Bärbel; Nguyen-Sträuli, Bich Doan; Kurzeder, Christian; Aybar, Danilo Díaz; Vorburger, Denise; Matlac, Dieter Michael; Ostapenko, Edvin; Riedel, Fabian; Fitzal, Florian; Meani, Francesco; Fick, Franziska; Sagasser, Jacqueline; Heil, Jörg; Karanlik, Hasan; Dedes, Konstantin J; Romics, Laszlo; Banys-Paluchowski, Maggie; Muslumanoglu, Mahmut; Perez, Maria Del Rosario Cueva; Díaz, Marcelo Chávez; Heidinger, Martin; Fehr, Mathias K; Reinisch, Mattea; Tukenmez, Mustafa; Maggi, Nadia; Rocco, Nicola; Ditsch, Nina; Gentilini, Oreste Davide; Paulinelli, Regis R; Zarhi, Sebastián Solé; Kuemmel, Sherko; Bruzas, Simona; di Lascio, Simona; Parissenti, Tamara K; Hoskin, Tanya L; Güth, Uwe; Ovalle, Valentina; Tausch, Christoph; Kuerer, Henry M; Caudle, Abigail S; Boileau, Jean-Francois; Boughey, Judy C; Kühn, Thorsten; Morrow, Monica; Weber, Walter P

Paclitaxel plus Eftilagimod Alpha, a Soluble LAG-3 Protein, in Metastatic, HR+ Breast Cancer: Results from AIPAC, a Randomized, Placebo Controlled Phase IIb Trial

紫杉醇联合可溶性 LAG-3 蛋白 Eftilagimod Alpha 治疗转移性 HR+ 乳腺癌:AIPAC 随机、安慰剂对照 IIb 期试验的结果

Wildiers, Hans; Armstrong, Anne; Cuypere, Eveline; Dalenc, Florence; Dirix, Luc; Chan, Steve; Marme, Frederik; Schröder, Carolina P; Huober, Jens; Duhoux, Francois P; Vuylsteke, Peter; Jager, Agnes; Brain, Etienne; Kuemmel, Sherko; Pápai, Zsuzsanna; Menke-van der Houven van Oordt, Catharina Willemien; Perjesi, Luca; Mueller, Christian; Brignone, Chrystelle; Triebel, Frederic